Koers Peloton Therapeutics, Inc.
Aandelen
PLTX
US70614L1044
Biotechnologie & Medisch Onderzoek
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Naseem Zojwalla
CTO | Chief Tech/Sci/R&D Officer | 51 | - |
Corporate Officer/Principal | - | - | |
Peter Stenge
PRN | Corporate Officer/Principal | - | - |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Helen Kim
BRD | Director/Board Member | 61 | 01-11-17 |
Brett A. Ringle
BRD | Director/Board Member | 73 | 01-01-11 |
David Chang
BRD | Director/Board Member | 64 | 01-02-18 |
Vaira. 1 jan. | Kapi. | |
---|---|---|
+18,15% | 124 mld. | |
+18,02% | 111 mld. | |
-12,75% | 23,17 mld. | |
+5,07% | 22,94 mld. | |
-39,94% | 17,42 mld. | |
-9,86% | 17,42 mld. | |
-14,97% | 16,9 mld. | |
+2,80% | 13,71 mld. | |
+27,39% | 11,82 mld. |